Comparative Immunology Microbiology and Infectious Diseases

Comparative Immunology Microbiology and Infectious Diseases 由 Elsevier Ltd 出版，属中科院农林科学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 Viral Infections and Vectors、Animal Disease Management and Epidemiology、Herpesvirus Infections and Treatments 等主题的论文，这 3 个主题约占 20%。（根据 OpenAlex 主题统计与中科院分区数据生成）

An International Journal focused on Comparative Veterinary and Medical ResearchComparative Immunology, Microbiology & Infectious Diseases aims to respond to the concept of "One Medicine - One Health" and to provide a venue for scientific exchange. Based on the concept of "Comparative Medicine" interdisciplinary cooperation between specialists in human and animal medicine is of mutual interest and benefit. Therefore, there is need to combine the respective interest of physicians, veterinarians and other health professionals for comparative studies relevant to either human or animal medicine .CIMID is mainly focusing on applied veterinary medicine with a particular focus on zoonotic pathogens. It includes etiology, biology, clinical diseases, epidemiology, diagnosis, control. Experimental in vitro studies and studies on laboratory animals are generally not accepted. Non infectious diseases are not accepted. Specific focus on human diseases can only be accepted if it concerns major zoonotic pathogens. Reviews are generally not accepted, except if they contain new or recent developments. CIMID does not accept manuscript focusing on Mycology.The journal is open to subjects of common interest related to the immunology, immunopathology, microbiology, parasitology and epidemiology of human and animal infectious diseases, especially zoonotic infections, and animal models of human infectious diseases. The role of environmental factors in disease emergence is emphasized. CIMID is mainly focusing on applied veterinary and human medicine rather than on fundamental experimental research.Original research papers of high quality and novelty on aspects of host response, molecular biology, pathogenesis, control and prevention and treatment of microbial and parasitic diseases of domestic animals and wildlife (if the infections are of zoonotic interest and/or in relation with domestic animals and/or can serve as a model for human diseases). Papers dealing primarily with epidemiology will be considered if they demonstrate a clear impact on the clinical features, pathogenesis or prevention of a disease. Similarly, articles addressing microbiology, parasitology, immunology or pathogenesis must address issues of comparative medical interest. Manuscripts focusing on probiotics or diseases and/or immunology of fishes are not part of our overall scope, as they are better fitted to more specialized journals. Manuscripts dealing with food hygiene and food risk are not part of our overall scope. Manuscripts dealing strictly with experimental design and fundamental research may not be considered depending the overall consequences for the knowledge of a disease.Review articles can be accepted. They should focus either on a pathogen or on analyses of the mechanisms of host-pathogen interactions including epidemiological studies. Proposal for such manuscripts should be submitted to the Co-Editors in Chief for approval before submitting the manuscript.Papers focusing solely on diagnostic techniques, case reports or drug trials will generally not be accepted. Papers of geographically limited interest, which repeat what had been established elsewhere, will not be considered. The readership of the journal is global. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.Papers will be rejected if standards of care of, or procedures performed on animals are not beyond those expected of humane veterinary care. Standards must, at least, meet the International Guiding Principles for Biomedical Research involving Animals, as issued by the Council for International Organizations of Medical Sciences. (C.I.O.M.S., c/o WHO, CH 1211 Geneva 27, Switzerland).Instruction for Authors:Comparative Immunology, Microbiology & Infectious Diseases consists of six issues a year and publishes original papers or reviews of the status of current research relative to the different

摘自期刊官网 Aims & Scope

研究方向（LetPub）：医学-免疫学

主编 Frederic Beugnet Lyon出版商官网

编委会国家分布：中国大陆 5 位（约 28%）；主要国家 中国 5、美国 5、法国 5、英国 2、南非 1（共 18 位编委标注了国家） 编委会 ↗出版商官网 · 2026-10-01

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

2.41LetPub · 2026-09-13

影响因子（出版商公布）

2.5出版商官网 · 2026-10-01

CiteScore 2026-06

4.4LetPub · 2026-09-13

CiteScore（出版商公布）

4.4出版商官网 · 2026-10-01

SJR 2026-06

0.6LetPub · 2026-09-13

SNIP 2026-06

0.92LetPub · 2026-09-13

h-index

48LetPub · 2026-09-13

h-index

87OpenAlex · 2026-10-01

i10-index

1,356OpenAlex · 2026-10-01

两年平均被引

2.23OpenAlex · 2026-10-01

自引率

4%LetPub · 2026-09-13

Gold OA 文章占比

12.99%LetPub · 2026-09-13

发文规模

年文章数

75LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

平均3月LetPub · 2026-09-13

平均录用比例（社区反馈）

25%LetPub · 2026-09-13

投稿到首次决定

7 天出版商官网 · 2026-10-01

外审后首次决定

40 天出版商官网 · 2026-10-01

投稿到接收

66 天出版商官网 · 2026-10-01

接收到发表

3 天出版商官网 · 2026-10-01

评审方式

单盲同行评审出版商官网

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

Elsevier Ltd

出版国家或地区

ENGLAND

出版语言

Multi-Language

出版周期

Bimonthly

创刊年份

1978

ISSN

0147-9571

电子版 ISSN

1878-1667

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗出版商官网
• 专刊 / 特刊征稿 ↗出版商官网